PKDREJ

Across TCGA pan-cancer cohorts, PKDREJ Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated PKDREJ data layer compared with 21 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher PKDREJ Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated PKDREJ expression acts as an unfavorable survival marker, although some lineages such as UCEC and STAD show a favorable association.

UCEC, STAD, and ACC are the cancer types where PKDREJ Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.834	0.621	.002	32	view →
STAD	DFS	Median	II,III,IV	1.000	0.373	.010	21	view →
ACC	DFS	Median	All	0.195	0.748	.003	9	view →
LIHC	DFS	Median	II,III,IV	0.044	0.427	<.001	9	view →
COAD	OS	Median	IV	0.140	0.657	.035	3	view →
SKCM	OS	Median	II,III,IV	0.946	0.828	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

PKDREJ–UCEC (DFS)

Open the UCEC breakdown →